Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention
Key result
Individualizing the duration of dual antiplatelet therapy optimizes treatment for patients following acute coronary syndrome or percutaneous coronary intervention.
Authors
Discussion
Loading...
Member takes
Implication
May support individualized DAPT post-ACS/PCI; leaves open need for randomized confirmation.
Key Points
Key points are not available for this paper at this time.
Cite This Study
Bagai et al. (2016) studied this question. Individualizing the duration of dual antiplatelet therapy optimizes treatment for patients following acute coronary syndrome or percutaneous coronary intervention.